Eric Harrison
Cardiovascular Disease · Tampa, FLNPI 1962488221
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $33,300 of the $34,502 with a category attached, or 96.5%. Canon Medical Informatics, Inc. accounts for 96.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $30,719 and has fallen 89.5% since, to $3,224 in 2024. Among cardiovascular disease clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $565.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Canon Medical Informatics, Inc.$33K
- Boston Scientific$216
- Novartis$154
- Sanofi-aventis U.S. LLC$144
- E.r. Squibb & Sons, L.L.C.$134
- Abbott$90
- plus $463 from 11 others
Across 4 payments — averaging $38,325 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Canon Medical Informatics, Inc.$153K
What the payments were for
- Speaking & faculty fees$33,30097%
- Food & beverage$1,2023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Canon Medical Informatics, Inc. | 3 | $33,300 |
| Boston Scientific | 4 | $216 |
| Novartis | 8 | $154 |
| Sanofi-aventis U.S. LLC | 9 | $144 |
| E.r. Squibb & Sons, L.L.C. | 8 | $134 |
| Abbott | 4 | $90 |
| Johnson & Johnson | 5 | $81 |
| AstraZeneca | 4 | $70 |
| Edwards Lifesciences | 3 | $63 |
| Amgen | 3 | $61 |
| Arbor Pharmaceuticals, Inc. | 3 | $53 |
| Pfizer | 2 | $32 |
| Scpharmaceuticals Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Medicomp Inc | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vitrea$30,100
- Vitrea V-Score$3,199
- OPTICROSS$170
How this compares
$34,502 in reported general payments places this provider in the 90th percentile of 1,740 cardiovascular disease providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorthalidone | 13 | $132 |
| Rosuvastatin Calcium | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Tampa
- Hiram BezerraTampa$698K
- James SmithTampa$324K
- David WilsonTampa$258K
- Robby WuTampa$190K
- Jason FelibertiTampa$138K
- Samip VasaiwalaTampa$126K
- Kevin MakatiLutz$1.6M
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.